General Information
Version
6.1
Revision date
2022-09-28
Product name
FACILISOLV
1.2.1 Relevant identified uses
Professional use
supplier name
Other
Emergency telephone
+33 (0) 1 72 11 00 03, 0344 892 0111
Icons in SDS
Company Information
company name
Dehon Service SAS
e-mail address of the competent person responsible for the Safety Data Sheet
ContactFDS@climalife.dehon.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H332, H336, H412
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07
Signal word
Warning
Contains
trans-dichloroethylene
Hazard statements
H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H336 - May cause drowsiness or dizziness. H412 - Harmful to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing vapours. P273 - Avoid release to the environment. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 - Call doctor, a POISON CENTER if you feel unwell. P501 - Dispose of contents/container to an approved waste disposal plant.
Supplemental label elements
EUH018 - In use may form flammable/explosive vapour-air mixture.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component trans-dichloroethylene (156-60-5) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects No additional information available 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 Signal word (CLP) : Warning Contains
